跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 324 条关于
“QXO”
全部
324
临床试验
44
药物
272
机构
2
资讯
6
去年
QXO Secures $830 Million in Private Placement and Prices $500 Million Common Stock Offering for Beacon Acquisition
去年
Ixo-Vec Gene Therapy Shows Long-Term Promise for Wet AMD in LUNA and OPTIC Trials
去年
Adverum's Ixo-vec Gene Therapy Shows Sustained Benefit in Wet AMD at 52 Weeks
去年
Adverum's Ixo-vec Shows Promise in Wet AMD Phase 2 Trial, Phase 3 Planned for 2025
9个月前
Two Novel Therapies Show Promise for Neovascular AMD: Duravyu Insert and Ixo-vec Gene Therapy Demonstrate Safety and Efficacy in Phase 2 Trials
3个月前
PurMinds Files Fiscal Q2 2026 Financials, Advances PCAOB Audit Toward OTCQB/QX Uplisting